Juno Therapeutics Investors

Juno Therapeutics is a prominent venture capital fund based in Seattle, Washington, founded in 2013 The firm specializes in advancing innovative therapies in the field of immuno-oncology With a significant investment scale of $264,600,000, Juno Therapeutics is dedicated to developing groundbreaking treatments for cancer The organization focuses on harnessing the power of the immune system to provide effective solutions for patients Juno Therapeutics is committed to fostering scientific advancements and improving patient outcomes through strategic investments

Invests into

Industry: FemTech
Headquarters: Seattle, Washington, United States
Founded Date: 2013
Employees Number: 663
Investor Type: Venture Capital Funds

Visit Website
Info@junotherapeuticscom
https://wwwtwittercom/junothera
Register and Claim Ownership